FibroScan®

A Non-Invasive Leap in Liver Health Assessment

Liver disease is a growing concern, often progressing silently until significant damage has occurred. Traditional diagnostic methods, while effective, can be invasive and carry inherent risks. Ramin Farboud MD is at the forefront of liver health assessment, offering FibroScan® – a revolutionary, non-invasive technology that provides rapid and accurate insights into liver stiffness and fat content. This advanced procedure empowers both patients and physicians with crucial information, enabling earlier diagnosis, more precise monitoring, and ultimately, better management of various liver conditions.

Arrow Icon

Understanding
Liver Stiffness and Fat

Liver stiffness, or fibrosis, is a key indicator of liver damage. It occurs when healthy liver tissue is replaced by scar tissue, impairing the liver's ability to function properly. As fibrosis progresses, it can lead to cirrhosis and even liver cancer. Similarly, excess fat accumulation in the liver, known as steatosis or fatty liver disease, can contribute to inflammation and damage. FibroScan® precisely measures both of these critical parameters, providing a comprehensive view of liver health without the need for a biopsy.

Fibroscan - 1

Your physician may recommend a FibroScan® test
if you have one of the following chronic liver conditions:

Checkmark Icon

Autoimmune Hepatitis

Checkmark Icon

Cirrhosis

Checkmark Icon

Genetic Diseases

Row rect Shape Decorative svg added to top
Checkmark Icon

Hepatitis B & C

Checkmark Icon

Alcoholic Liver Disease

Checkmark Icon

Non-Alcoholic Steatohepatitis

The Science Behind FibroScan®

FibroScan® utilizes transient elastography (TE) technology to assess liver stiffness. A small probe, similar to an ultrasound transducer, emits a gentle, painless shear wave into the liver. The speed at which this wave travels through the liver tissue is directly proportional to its stiffness. Faster wave propagation indicates greater stiffness, signifying more advanced fibrosis. Simultaneously, the device employs Controlled Attenuation Parameter (CAP) technology to quantify liver fat. This dual assessment provides a robust diagnostic profile.

Fibroscan - 2

A Non-Invasive
Alternative to Biopsy

For decades, liver biopsy has been the gold standard for diagnosing and staging liver fibrosis and steatosis. However, a biopsy is an invasive procedure that involves inserting a needle into the liver to extract a tissue sample. This carries risks such as pain, bleeding, and, in rare cases, more serious complications. FibroScan® offers a safe, non-invasive, and equally effective alternative, making it a preferred choice for many patients and clinicians. It eliminates the need for hospitalization and extensive recovery time.

Quick, Comfortable,
and Convenient

The FibroScan® procedure is remarkably quick and comfortable, typically taking only 5 to 10 minutes to complete. Patients simply lie on their back with their right arm raised above their head. A trained technician then applies a water-based gel to the skin over the liver and places the FibroScan® probe on the chest, gently pressing it against the skin. Most patients report feeling only a slight vibration or pressure during the examination, with no pain or discomfort. Its ease of use makes it suitable for frequent monitoring.

Fibroscan - 3

Broad Applications in Liver Disease Management

FibroScan® has become an invaluable tool in the management of a wide range of liver conditions. It is particularly useful for assessing fibrosis and steatosis in patients with chronic hepatitis B and C, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), alcoholic liver disease, and metabolic syndrome. It aids in initial diagnosis, staging of disease severity, monitoring disease progression, and evaluating the effectiveness of treatment regimens. Its versatility makes it a cornerstone of modern hepatology.

Empowering Patients and Physicians

By providing immediate, objective, and reproducible results, FibroScan® empowers both patients and physicians. Patients gain a clearer understanding of their liver health, which can motivate adherence to lifestyle changes and treatment plans. For physicians, FibroScan® data allows for more informed clinical decisions, personalized treatment strategies, and proactive management of liver disease, ultimately leading to improved patient outcomes and a reduction in the burden of advanced liver disease.

Ramin Farboud MD is committed to utilizing cutting-edge technology like FibroScan® to provide the highest standard of care for liver health. If you are concerned about your liver health or have a risk factor for liver disease, contact Ramin Farboud MD today to learn more about how FibroScan® can benefit you. Take the first step towards better liver health.